The Supreme Court on Monday directed the Central Board of Secondary Education (CBSE) to take all necessary steps to declare the Class 12 Improvement Examination results as soon as possible. The court ...

The CBSE Class 12 Biotechnology syllabus for the 2026-27 academic year remains same as the previous year. It outlines the required chapters and subjects, assessment criteria, project work guidelines, ...

The CBSE Class 12 Biology syllabus for the 2026-27 academic year remains same as the previous year. It outlines the required chapters and subjects, assessment criteria, project work guidelines, and ...

In its annual Biotech Beyond Borders report, EY projects growth to continue throughout 2026, fueled primarily by the increased volume and value of M&A and licensing deals. (Techa Tungateja/GettyImages ...

Kosloff is a co-chair of a working group with the China Strategy Initiative at the Council on Foreign Relations and a senior fellow at American Economic Liberties Project. China’s rise is happening ...

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...

Marc Cummings, president and CEO of Life Science Washington, speaking at a one-day forum focused on AI-driven biotech that was held in Seattle in October 2025. (Life Science Washington Photo) Seattle ...

The deal was confirmed on Sunday, with both companies agreeing to a 100% share swap that will combine upGrad’s higher education and upskilling offerings with Unacademy’s K-12 and test preparation ...

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...

Unacademy, once one of India’s most valuable edtech startups, is set to be acquired by rival upGrad in an all-stock deal that would bring together two major online learning platforms in the country.

March 15 (Reuters) - Indian edtech startup upGrad has signed a term sheet ‌to acquire rival Unacademy in an all-stock deal, the companies said on Sunday. Sign up here. Unacademy founder and ⁠CEO ...

There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...